BRPI0518575A2 - composiÇço para revestimento entÉrico por pelÍcula contendo polÍmero micronizado com agente contra pega - Google Patents

composiÇço para revestimento entÉrico por pelÍcula contendo polÍmero micronizado com agente contra pega

Info

Publication number
BRPI0518575A2
BRPI0518575A2 BRPI0518575-0A BRPI0518575A BRPI0518575A2 BR PI0518575 A2 BRPI0518575 A2 BR PI0518575A2 BR PI0518575 A BRPI0518575 A BR PI0518575A BR PI0518575 A2 BRPI0518575 A2 BR PI0518575A2
Authority
BR
Brazil
Prior art keywords
coating composition
tackifier
film coating
film containing
enteric coating
Prior art date
Application number
BRPI0518575-0A
Other languages
English (en)
Inventor
Thomas Farrel
Kurt Fegely
George Reyes
Budhi Simon
Cara Young
Ali Rajabi-Siahboomi
Original Assignee
Bpsi Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36588225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0518575(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bpsi Holdings Inc filed Critical Bpsi Holdings Inc
Publication of BRPI0518575A2 publication Critical patent/BRPI0518575A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSIÇçO PARA REVESTIMENTO ENTÉRICO POR PELÍCULA CONTENDO POLÍMERO MICRONIZADO COM AGENTE CONTRA PEGA. A presente invenção descreve composições anidras de revestimento entérico por película e dispersões aquosas que as contêm. Quando aplicadas sobre substratos ingeríveis por via oral, tais como formas de dosagem sólidas orais, os revestimentos por película são capazes de impedir que os substratos se desintegrem em meios com valores de pH entre cerca de 1 e cerca de 4,5 ou valores mais altos. Uma composição de revestimento por película preferida contém um intermediário micronizado que compreende uma resina acrílica e talco. Vantajosa e surpreendentemente, a composição de revestimento por película não contém um agente alcalinizante.
BRPI0518575-0A 2004-12-17 2005-12-16 composiÇço para revestimento entÉrico por pelÍcula contendo polÍmero micronizado com agente contra pega BRPI0518575A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63708304P 2004-12-17 2004-12-17
PCT/US2005/046326 WO2006066264A1 (en) 2004-12-17 2005-12-16 Enteric film coating composition containing enteric polymer micronized with detackifier

Publications (1)

Publication Number Publication Date
BRPI0518575A2 true BRPI0518575A2 (pt) 2009-04-28

Family

ID=36588225

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518575-0A BRPI0518575A2 (pt) 2004-12-17 2005-12-16 composiÇço para revestimento entÉrico por pelÍcula contendo polÍmero micronizado com agente contra pega

Country Status (15)

Country Link
US (1) US20060134216A1 (pt)
EP (1) EP1827390A1 (pt)
JP (1) JP2008524257A (pt)
KR (1) KR20070094627A (pt)
CN (1) CN101080217B (pt)
AR (1) AR051722A1 (pt)
AU (1) AU2005316235A1 (pt)
BR (1) BRPI0518575A2 (pt)
CA (1) CA2586425A1 (pt)
IL (1) IL183579A0 (pt)
MX (1) MX2007007221A (pt)
NO (1) NO20073395L (pt)
TW (1) TW200626185A (pt)
WO (1) WO2006066264A1 (pt)
ZA (1) ZA200704311B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2051704B1 (de) * 2006-08-18 2012-04-18 Evonik Röhm GmbH Pharmazeutische Zusammensetzung mit kontrollierter Wirkstoffabgabe für Wirkstoffe mit guter Löslichkeit in Wasser
EP2429504A4 (en) * 2009-05-12 2013-05-01 Bpsi Holdings Llc FILM COATINGS WITH DECEPTORS IN FINE PARTICLE SIZES AND SUBSTRATES COATED THEREFOR
BRPI1007725A2 (pt) 2009-05-12 2016-02-16 Bpsi Holdings Llc composição de revestimento de liberação imediata com propriedades melhoradas de barreira à umidade, suspensão aquosa, substrato oral revestido, forma de dosagem oral e método para preparação da mesma
WO2011136376A1 (ja) * 2010-04-30 2011-11-03 武田薬品工業株式会社 腸溶性錠剤
US8920840B2 (en) * 2010-04-30 2014-12-30 Takeda Pharmaceutical Company Limited Enteric tablet
WO2014159814A1 (en) * 2013-03-13 2014-10-02 Patricia Oliver Formulations and tablets for treatment or prevention of neurological disorders
EP3307239B1 (en) 2015-06-12 2020-09-16 Vaxart, Inc. Formulations for small intestinal delivery of rsv and norovirus antigens
CN111954521B (zh) * 2018-04-12 2023-02-17 Bpsi控股有限责任公司 酸化包衣和由其包衣的抗崩解基质
US11458104B1 (en) 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet
CN116617174B (zh) * 2023-05-12 2024-03-08 石家庄四药有限公司 一种含硫酸氢氯吡格雷和阿司匹林的片剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US656457A (en) * 1900-05-11 1900-08-21 Isaac Hirsch Knife.
US2595076A (en) * 1949-09-19 1952-04-29 Hudson Bay Mining & Smelting Selective flotation of zinc
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
CN1162917A (zh) * 1994-10-07 1997-10-22 伯温德药品服务公司 肠内涂层组合物，用其涂覆的方法和涂覆制品
CN1093855C (zh) * 1995-09-21 2002-11-06 帕斯医药股份有限公司 新的含有对酸不稳定的奥美拉唑的组合物及其制备方法
US6623759B2 (en) * 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
EP1272165B1 (en) * 2000-02-10 2010-12-01 BPSI Holdings, Inc. Acrylic enteric coating compositions
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
US6703004B2 (en) * 2002-04-03 2004-03-09 Revlon Consumer Products Corporation Method and compositions for bleaching hair
US20040255399A1 (en) * 2003-06-23 2004-12-23 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Method and compositions for coloring hair with taurate copolymers

Also Published As

Publication number Publication date
US20060134216A1 (en) 2006-06-22
KR20070094627A (ko) 2007-09-20
CN101080217B (zh) 2012-07-18
CA2586425A1 (en) 2006-06-22
AU2005316235A1 (en) 2006-06-22
NO20073395L (no) 2007-09-07
WO2006066264A1 (en) 2006-06-22
ZA200704311B (en) 2008-06-25
CN101080217A (zh) 2007-11-28
TW200626185A (en) 2006-08-01
JP2008524257A (ja) 2008-07-10
EP1827390A1 (en) 2007-09-05
MX2007007221A (es) 2007-08-14
AR051722A1 (es) 2007-01-31
IL183579A0 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
NO20073395L (no) Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer
GEP20135724B (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
DE602006016607D1 (de) Härtbare organopolysiloxanharz-zusammensetzungen und daraus geformtes optisches teil
BRPI0615307A2 (pt) agonistas de adrenorreceptor alfa2c
PE20080697A1 (es) Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
MX2025003620A (es) Composiciones de ester de acido cannabinoide y sus usos
WO2008092006A3 (en) Antimicrobial compositions
MXPA04002167A (es) Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
EP2106809A3 (en) Bioadhesive composition formed using click chemistry
CL2009000316A1 (es) Compuestos derivados de urea de benzomorfanos y sus sales, inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de trastornos metabolicos.
MX342422B (es) Composiciones para aplicaciones de gel removible para uñas y metodos para su uso.
WO2007144394A3 (en) Pharmaceutical use of substituted piperidine carboxamides
EA018193B3 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
ECSP099634A (es) Derivados de piridazinona útiles como inhibidores de glucano sintasa
AU2008248129A8 (en) Gamma secretase modulators
BRPI0412029A (pt) formulações para microprojeções revestidas contendo contra-ìons não-voláteis
BRPI0509573A (pt) derivados de sulfonamida-tiazolpiridina como ativadores de glicocinase úteis para o tratamento de diabetes do tipo 2
WO2009031642A1 (ja) 医薬組成物
BR112012025592A2 (pt) moduladores do receptor de gpr119 e o tratamento de distúrbios relacionados com os mesmos
TW200740799A (en) Alpha2C adrenoreceptor agonists
WO2007093450A3 (en) Deuterated catecholamine derivatives and medicaments comprising said compounds
BRPI0513252A (pt) agente de revestimento de proteção contra corrosão para componentes de metal e processo para a sua preparação
BRPI0905369B8 (pt) composição farmacêutica, uso da composição farmacêutica e kit compartimentado
MX2022002183A (es) Composiciones de éster de ácido cannabinoide y sus usos.

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: BASEADO NO ARTIGO 216 1O DA LPI, APRESENTE COPIA AUTENTICADA DA PROCURACAO PARA QUE ESTA SEJA ACEITA. E AINDA, ESCLARECA A DIVERGENCIA ENTRE O NOME QUE CONSTA NA PROCURACAO E AQUELE PREENCHIDO NO CAMPO DO DEPOSITANTE.

B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]